ArticleJournal of diabetes and metabolic disorders2026

Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndrome.

Marjan Khorsand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.